The HoLISTIC Consortium which LaRDR participates and contributes data has two posters on the
Identification of Risk Categories from the Advanced-Stage Hodgkin International Prognostic Index (A-HIPI) Model: A Detailed Analysis from the Hodgkin Lymphoma International Study for Individual Care (HoLISTIC) Consortium; and
Development and Validation of the Early-Stage Hodgkin Lymphoma International Prognostication Index (E-HIPI): A Report from the Hodgkin Lymphoma International Study for Individual Care (HoLISTIC) Consortium.
Congratulations to the HoLISTIC colleagues, and Prof Stephen Opat and A/Prof Eliza Hawkes for leading the collaboration on LaRDR’s behalf.
The international SMZL study which LaRDR participates and contributes data has a poster on the Favorable Outcomes of Splenic Marginal Zone Lymphoma in an International Study of 934 Patients with Long Follow-up.
Congratulations to the SMZL study colleagues, and Prof Chan Cheah and Dr Elizabeth Smyth for leading the collaboration on LaRDR’s behalf.